绿帽社

MEG@绿帽社 Comprehensive Training (Second Edition)

Monday, November 16, 2015toFriday, November 20, 2015

It is with great pleasure that we are announcing the 2nd edition of the MEG@绿帽社 Comprehensive Training Program in 2015.3801 rue University, Montreal, QC, H3A 2B4, CA/bicCategory:聽MNI

Sylvain Baillet inducted into the Royal Society of Canada

Published: 4 September 2025

Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life...

Neuro Epilepsy Lecture Series: AI in Epilepsy: From Diagnosis to Continuous Monitoring

Thursday, September 25, 2025 16:00to17:00

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research./neuroCategory:聽Medicine and Health Sciences MNI

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

Thursday, November 13, 2025 16:00to17:00

Established in 1935, the Hughlings Jackson Lecture is The Neuro鈥檚 premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the...

8th National Neuromuscular Review Course

Friday, October 24, 2025 09:00toSaturday, October 25, 2025 17:00

Dr. Nicolas Dupr茅 of Laval University, Dr. Karine Garneau of Universit茅 de Montr茅al, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course...

iPSC Seminars: Early Drug Discovery Unit (EDDU)

Thursday, October 2, 2025 11:00to12:00

THE NEURO'S EDDU iPSC SEMINAR SERIES聽 Modeling 伪-Synuclein Pathology Spreading in a 3D Human Midbrain-Striatal Assembloid/neuroCategory:聽Medicine Research Medicine and Health Sciences MNI

6th National Course on Sleep Medicine

Friday, November 28, 2025 09:00toSaturday, November 29, 2025 16:00

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.3801 rue University, Montreal, QC, H3A 2B4, CA/neuroCategory:聽Medicine Research...

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Pages

聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽

The Neuro logo绿帽社 logo

聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽

Back to top